These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 30484395)

  • 21. High-risk behaviors and hospitalizations among gamma hydroxybutyrate (GHB) users.
    Kim SY; Anderson IB; Dyer JE; Barker JC; Blanc PD
    Am J Drug Alcohol Abuse; 2007; 33(3):429-38. PubMed ID: 17613970
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of the pharmacokinetic and pharmacodynamic interaction between gamma-hydroxybutyrate and ethanol in the rat.
    Van Sassenbroeck DK; De Paepe P; Belpaire FM; Buylaert WA
    Toxicol Sci; 2003 Jun; 73(2):270-8. PubMed ID: 12700396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sodium oxybate: new drug. Fewer attacks of cataplexy in some patients.
    Prescrire Int; 2007 Jun; 16(89):98-101. PubMed ID: 17582923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determination of GHB and GHB-β-O-glucuronide in hair of three narcoleptic patients-Comparison between single and chronic GHB exposure.
    Mehling LM; Wang X; Johansen SS; Spottke A; Heidbreder A; Young P; Madea B; Hess C
    Forensic Sci Int; 2017 Sep; 278():e8-e13. PubMed ID: 28811136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sodium oxybate-induced central sleep apneas.
    Frase L; Schupp J; Sorichter S; Randelshofer W; Riemann D; Nissen C
    Sleep Med; 2013 Sep; 14(9):922-4. PubMed ID: 23834969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The nightly administration of sodium oxybate results in significant reduction in the nocturnal sleep disruption of patients with narcolepsy.
    Black J; Pardi D; Hornfeldt CS; Inhaber N
    Sleep Med; 2009 Sep; 10(8):829-35. PubMed ID: 19616998
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapid occurrence of depression following addition of sodium oxybate to modafinil.
    Rossetti AO; Heinzer RC; Tafti M; Buclin T
    Sleep Med; 2010 May; 11(5):500-1. PubMed ID: 20133191
    [No Abstract]   [Full Text] [Related]  

  • 28. Weekly gamma-hydroxybutyrate exposure sensitizes locomotor hyperactivity to low-dose 3,4-methylenedioxymethamphetamine in rats.
    van Nieuwenhuijzen PS; Li KM; Hunt GE; McGregor IS
    Neuropsychobiology; 2009; 60(3-4):195-203. PubMed ID: 19893336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Restless legs syndrome in narcolepsy: a side effect of sodium oxybate?
    Abril B; Carlander B; Touchon J; Dauvilliers Y
    Sleep Med; 2007 Mar; 8(2):181-3. PubMed ID: 17275405
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increase in sleep-related breathing disturbances after treatment with sodium oxybate in patients with narcolepsy and mild obstructive sleep apnea syndrome: two case reports.
    Seeck-Hirschner M; Baier PC; von Freier A; Aldenhoff J; Göder R
    Sleep Med; 2009 Jan; 10(1):154-5. PubMed ID: 18226949
    [No Abstract]   [Full Text] [Related]  

  • 31. Sodium oxybate in the treatment of childhood narcolepsy-cataplexy: a retrospective study.
    Mansukhani MP; Kotagal S
    Sleep Med; 2012 Jun; 13(6):606-10. PubMed ID: 22445591
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sodium oxybate: a review of its use in the management of narcolepsy.
    Robinson DM; Keating GM
    CNS Drugs; 2007; 21(4):337-54. PubMed ID: 17381187
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Weight loss in narcolepsy patients treated with sodium oxybate.
    Husain AM; Ristanovic RK; Bogan RK
    Sleep Med; 2009 Jun; 10(6):661-3. PubMed ID: 19014899
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Gamma-hydroxybutyric acid (GHB) dependence and the GHB withdrawal syndrome: diagnosis and treatment].
    van Noorden MS; Kamal R; de Jong CA; Vergouwen AC; Zitman FG
    Ned Tijdschr Geneeskd; 2010; 154():A1286. PubMed ID: 21040601
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Narcolepsy: action of two gamma-aminobutyric acid type B agonists, baclofen and sodium oxybate.
    Huang YS; Guilleminault C
    Pediatr Neurol; 2009 Jul; 41(1):9-16. PubMed ID: 19520267
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sodium Oxybate-Associated Confusion in the Older Adult.
    Doshi V; Cross C; Muppavarapu K
    Am J Ther; 2018; 25(6):e678. PubMed ID: 28614089
    [No Abstract]   [Full Text] [Related]  

  • 37. Possible long-term effects of γ-hydroxybutyric acid (GHB) due to neurotoxicity and overdose.
    van Amsterdam JG; Brunt TM; McMaster MT; Niesink RJ
    Neurosci Biobehav Rev; 2012 Apr; 36(4):1217-27. PubMed ID: 22342779
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Variety of symptoms after drug use of gamma-hydroxybutyric acid (GHB)].
    Galldiks N; Kadow I; Bechdolf A; Fink GR; Klosterkötter J; Kuhn J
    Fortschr Neurol Psychiatr; 2011 Jan; 79(1):21-5. PubMed ID: 21154180
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sodium Oxybate Treatment in Pediatric Type 1 Narcolepsy.
    Moresco M; Pizza F; Antelmi E; Plazzi G
    Curr Drug Metab; 2018; 19(13):1073-1079. PubMed ID: 29512449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gamma-hydroxybutyrate (GHB) in humans: pharmacodynamics and pharmacokinetics.
    Abanades S; Farré M; Segura M; Pichini S; Barral D; Pacifici R; Pellegrini M; Fonseca F; Langohr K; De La Torre R
    Ann N Y Acad Sci; 2006 Aug; 1074():559-76. PubMed ID: 17105953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.